Filter
99
Filtered Results: 99
Text search:
hydroxychloroquine
Featured
Recommendations
24
New Publications
11
Language
Document type
Guidelines
58
Studies & Reports
16
No document type
10
Fact sheets
4
Manuals
3
Resource Platforms
3
Infographics
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Brazil
11
India
9
Germany
6
Latin America and the Carribbean
5
Russia
5
Ethiopia
3
West and Central Africa
3
Guinea-Bissau
2
Kenya
2
South Africa
2
Mozambique
2
Angola
2
East and Southern Africa
2
Middle East and North Africa
2
Global
2
Nigeria
1
Philippines
1
South Sudan
1
Syria
1
Thailand
1
Bangladesh
1
Central African Republic
1
Argentina
1
Namibia
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Austria
1
Switzerland
1
Serbia
1
Ukraine
1
Ecuador
1
Bolivia
1
Chile
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Bhutan
1
Armenia
1
Tajikistan
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Mauritius
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
59
Clinical Guidelines
6
Key Resources
2
Annual Report MEDBOX
1
Public Health
1
Toolboxes
COVID-19
70
Pharmacy
9
Rapid Response
2
Caregiver
2
NTDs
2
Polio
1
Conflict
1
Mental Health
1
TB
1
AMR
1
NCDs
1
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have similar effects on the heart.
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
The ten mythbusters, available in English and Siswati, were developed based on feedback received from chiefdom leadership who identified prevailing myths and misconceptions related to COVID-19 prevention, treatment or stigma related to recovery.
Key mythbusters tackle use of alcohol, garlic, hot ...
CDC Afrique est préoccupé par les informations inexactes distribués par les médias traditionnels et sociaux en ce qui concerne la prévention et le traitement des maladies nouvelles coronavirus (Covid-19).
Sur la base d’un examen des preuves et de l’évaluation d’experts, le CDC Afrique r...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By...
Updated Treatment Guidelines
Solomon Islands pharmacy staff have developed an essential medicines supplies list. It was a collaborative effort involving a lot of staff taking the pictures and putting it all together. The list was launched as an initiative to improve the availability of medical stock within the country
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section...
Here you can download infographics and posters
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information from trustworthy sources. Information is presented in...
